Early applications of granulocyte colony-stimulating factor (G-CSF) can stabilize the blood-optic-nerve barrier and ameliorate inflammation in a rat model of anterior ischemic optic neuropathy (rAION)
Yao-Tseng Wen, Tzu-Lun Huang, Sung-Ping Huang, Chung-Hsing Chang, Rong-Kung Tsai, Yao-Tseng Wen, Tzu-Lun Huang, Sung-Ping Huang, Chung-Hsing Chang, Rong-Kung Tsai
Abstract
Granulocyte colony-stimulating factor (G-CSF) was reported to have a neuroprotective effect in a rat model of anterior ischemic optic neuropathy (rAION model). However, the therapeutic window and anti-inflammatory effects of G-CSF in a rAION model have yet to be elucidated. Thus, this study aimed to determine the therapeutic window of G-CSF and investigate the mechanisms of G-CSF via regulation of optic nerve (ON) inflammation in a rAION model. Rats were treated with G-CSF on day 0, 1, 2 or 7 post-rAION induction for 5 consecutive days, and a control group were treated with phosphate-buffered saline (PBS). Visual function was assessed by flash visual evoked potentials at 4 weeks post-rAION induction. The survival rate and apoptosis of retinal ganglion cells were determined by FluoroGold labeling and TUNEL assay, respectively. ON inflammation was evaluated by staining of ED1 and Iba1, and ON vascular permeability was determined by Evans Blue extravasation. The type of macrophage polarization was evaluated using quantitative real-time PCR (qRT-PCR). The protein levels of TNF-α and IL-1β were analyzed by western blotting. A therapeutic window during which G-CSF could rescue visual function and retinal ganglion cell survival was demonstrated at day 0 and day 1 post-infarct. Macrophage infiltration was reduced by 3.1- and 1.6-fold by G-CSF treatment starting on day 0 and 1 post-rAION induction, respectively, compared with the PBS-treated group (P<0.05). This was compatible with 3.3- and 1.7-fold reductions in ON vascular permeability after G-CSF treatment compared with PBS treatment (P<0.05). Microglial activation was increased by 3.8- and 3.2-fold in the early (beginning treatment at day 0 or 1) G-CSF-treated group compared with the PBS-treated group (P<0.05). Immediate (within 30 mins of infarct) treatment with G-CSF also induced M2 microglia/macrophage activation. The cytokine levels were lower in the group that received immediate G-CSF treatment compared to those in the later G-CSF treatment group (P<0.05). Early treatment with G-CSF stabilized the blood-ON barrier to reduce macrophage infiltration and induced M2 microglia/macrophage polarization to decrease the expressions of pro-inflammatory cytokines in this rAION model.
Keywords: Blood–optic-nerve barrier; Granulocyte colony-stimulating factor (G-CSF); Macrophage infiltration; Microglia/macrophage polarization; Rat anterior ischemic optic neuropathy (rAION).
Conflict of interest statement
The authors declare no competing or financial interests.
© 2016. Published by The Company of Biologists Ltd.
Figures
References
- Bernstein S. L. and Miller N. R. (2015). Ischemic optic neuropathies and their models: disease comparisons, model strengths and weaknesses. Jpn. J. Ophthalmol. 59, 135-147. 10.1007/s10384-015-0373-5
- Bernstein S. L., Johnson M. A. and Miller N. R. (2011). Nonarteritic anterior ischemic optic neuropathy (NAION) and its experimental models. Prog. Retin. Eye Res. 30, 167-187. 10.1016/j.preteyeres.2011.02.003
- Chang C. H., Huang T. L., Huang S. P. and Tsai R. K. (2014). Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in a rat model of anterior ischemic optic neuropathy (rAION). Exp. Eye Res. 118, 109-116. 10.1016/j.exer.2013.11.012
- Cui Q., Yin Y. and Benowitz L. I. (2009). The role of macrophages in optic nerve regeneration. Neuroscience 158, 1039-1048. 10.1016/j.neuroscience.2008.07.036
- Doycheva D. M., Hadley T., Li L., Applegate R. L. II, Zhang J. H. and Tang J. (2014). Anti-neutrophil antibody enhances the neuroprotective effects of G-CSF by decreasing number of neutrophils in hypoxic ischemic neonatal rat model. Neurobiol. Dis. 69, 192-199. 10.1016/j.nbd.2014.05.024
- Frank T., Schlachetzki J. C., Göricke B., Meuer K., Rohde G., Dietz G. P. H., Bähr M., Schneider A. and Weishaupt J. H. (2009). Both systemic and local application of granulocyte-colony stimulating factor (G-CSF) is neuroprotective after retinal ganglion cell axotomy. BMC Neurosci. 10, 49 10.1186/1471-2202-10-49
- Giulian D., Chen J., Ingeman J. E., George J. K. and Noponen M. (1989). The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J. Neurosci. 9, 4416-4429.
- Goldenberg-Cohen N., Guo Y., Margolis F., Cohen Y., Miller N. R. and Bernstein S. L. (2005). Oligodendrocyte dysfunction after induction of experimental anterior optic nerve ischemia. Invest. Ophthalmol. Vis. Sci. 46, 2716-2725. 10.1167/iovs.04-0547
- Guo Y., Liu S., Wang P., Zhang H., Wang F., Bing L., Gao J., Yang J. and Hao A. (2014). Granulocyte colony-stimulating factor improves neuron survival in experimental spinal cord injury by regulating nucleophosmin-1 expression. J. Neurosci. Res. 92, 751-760. 10.1002/jnr.23362
- Hartung T., Docke W. D., Gantner F., Krieger G., Sauer A., Stevens P., Volk H. D. and Wendel A. (1995). Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 85, 2482-2489.
- Hattenhauer M. G., Leavitt J. A., Hodge D. O., Grill R. and Gray D. T. (1997). Incidence of nonarteritic anteripr ischemic optic neuropathy. Am. J. Ophthalmol. 123, 103-107. 10.1016/S0002-9394(14)70999-7
- Hayreh S. S. (2009). Ischemic optic neuropathy. Prog. Retin. Eye Res. 28, 34-62. 10.1016/j.preteyeres.2008.11.002
- Hayreh S. S. (2013). Ischemic optic neuropathies – where are we now? Graefes Arch. Clin. Exp. Ophthalmol. 251, 1873-1884. 10.1007/s00417-013-2399-z
- Hayreh S. S. and Zimmerman M. B. (2008). Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology 115, 298-305. 10.1016/j.ophtha.2007.05.027
- Heiduschka P. and Schraermeyer U. (2008). Comparison of visual function in pigmented and albino rats by electroretinography and visual evoked potentials. Graefes Arch. Clin. Exp. Ophthalmol. 246, 1559-1573. 10.1007/s00417-008-0895-3
- Huang T. L., Chang C. H., Lin K. H., Sheu M. M. and Tsai R. K. (2011). Lack of protective effect of local administration of triamcinolone or systemic treatment with methylprednisolone against damages caused by optic nerve crush in rats. Exp. Eye Res. 92, 112-119. 10.1016/j.exer.2010.12.008
- Huang T. L., Huang S. P., Chang C. H., Lin K. H., Sheu M. M. and Tsai R. K. (2014). Factors influencing the retrograde labeling of retinal ganglion cells with fluorogold in an animal optic nerve crush model. Ophthalmic. Res. 51, 173-178. 10.1159/000357736
- Huang T. L., Huang S. P., Chang C. H., Lin K. H., Chang S. W. and Tsai R. K. (2015). Protective effects of systemic treatment with methylprednisolone in a rodent model of non-arteritic anterior ischemic optic neuropathy (rAION). Exp. Eye Res. 131, 69-76. 10.1016/j.exer.2014.12.014
- Huang S. P., Fang K. T., Chang C. H., Huang T. L., Wen Y. T. and Tsai R. K. (2016). Autocrine protective mechanisms of human granulocyte colony-stimulating factor (G-CSF) on retinal ganglion cells after optic nerve crush. Exp. Eye Res. 143, 132-140. 10.1016/j.exer.2015.10.010
- Johnson L. N. and Arnold A. C. (1994). Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California. J. Neuroophthalmol. 14, 38-44. 10.1097/00041327-199403000-00011
- Kadota R., Koda M., Kawabe J., Hashimoto M., Nishio Y., Mannoji C., Miyashita T., Furuya T., Okawa A., Takahashi K. et al. (2012). Granulocyte colony-stimulating factor (G-CSF) protects oligodendrocyte and promotes hindlimb functional recovery after spinal cord injury in rats. PLoS ONE 7, e50391 10.1371/journal.pone.0050391
- Lee S. T., Chu K., Jung K. H., Ko S. Y., Kim E. H., Sinn D. I., Lee Y. S., Lo E. H., Kim M. and Roh J. K. (2005). Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Res. 1058, 120-128. 10.1016/j.brainres.2005.07.076
- Lee G. H., Stanford M. P., Shariati M. A., Ma J. H. and Liao Y. J. (2014). Severe, early axonal degeneration following experimental anterior ischemic optic neuropathy. Invest. Ophthalmol. Vis. Sci. 55, 7111-7118. 10.1167/iovs.14-14603
- Leskovar A., Moriarty L. J., Turek J. J., Schoenlein I. A. and Borgens R. B. (2000). The macrophage in acute neural injury: changes in cell numbers over time and levels of cytokine production in mammalian central and peripheral nervous systems. J. Exp. Biol. 203, 1783-1795.
- Li L., Klebe D., Doycheva D., McBride D. W., Krafft P. R., Flores J., Zhou C., Zhang J. H. and Tang J. (2015). G-CSF ameliorates neuronal apoptosis through GSK-3β inhibition in neonatal hypoxia-ischemia in rats. Exp. Neurol. 263, 141-149. 10.1016/j.expneurol.2014.10.004
- Nakazawa T., Nakazawa C., Matsubara A., Noda K., Hisatomi T., She H., Michaud N., Hafezi-Moghadam A., Miller J. W. and Benowitz L. I. (2006). Tumor necrosis factor-α mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J. Neurosci. 26, 12633-12641. 10.1523/JNEUROSCI.2801-06.2006
- Nicholson J. D., Leiba H. and Goldenberg-Cohen N. (2014). Translational preclinical research may lead to improved medical management of non-arteritic anterior ischemic optic neuropathy. Front. Neurol. 5, 122 10.3389/fneur.2014.00122
- Nishiki S., Hato F., Kamata N., Sakamoto E., Hasegawa T., Kimura-Eto A., Hino M. and Kitagawa S. (2004). Selective activation of STAT3 in human monocytes stimulated by G-CSF: implication in inhibition of LPS-induced TNF-alpha production. Am. J. Physiol. Cell Physiol. 286, 21 10.1152/ajpcell.00387.2003
- Oishi A., Otani A., Sasahara M., Kojima H., Nakamura H., Yodoi Y. and Yoshimura N. (2008). Granulocyte colony-stimulating factor protects retinal photoreceptor cells against light-induced damage. Invest. Ophthalmol. Vis. Sci. 49, 5629-5635. 10.1167/iovs.08-1711
- Orihuela R., McPherson C. A. and Harry G. J. (2016). Microglial M1/M2 polarization and metabolic states. Br. J. Pharmacol. 173, 649-665. 10.1111/bph.13139
- Rakos G., Kis Z., Nagy D., Lur G., Farkas T., Hortobagyi T., Vecsei L. and Toldi J. (2007). Evans Blue fluorescence permits the rapid visualization of non-intact cells in the perilesional rim of cold-injured rat brain. Acta. Neurobiol. Exp. (Wars) 67, 149-154.
- Salgado C., Vilson F., Miller N. R. and Bernstein S. L. (2011). Cellular inflammation in nonarteritic anterior ischemic optic neuropathy and its primate model. Arch. Ophthalmol. 129, 1583-1591. 10.1001/archophthalmol.2011.351
- Scheppke L., Aguilar E., Gariano R. F., Jacobson R., Hood J., Doukas J., Cao J., Noronha G., Yee S., Weis S. et al. (2008). Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits. J. Clin. Invest. 118, 2337-2346. 10.1172/jci33361
- Selvaraju R., Bernasconi L., Losberger C., Graber P., Kadi L., Avellana-Adalid V., Picard-Riera N., Van Evercooren A. B., Cirillo R., Kosco-Vilbois M. et al. (2004). Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro. Mol. Cell Neurosci. 25, 707-721. 10.1016/j.mcn.2003.12.014
- Shima C., Adachi Y., Minamino K., Okigaki M., Shi M., Imai Y., Yanai S., Takahashi K. and Ikehara S. (2012). Neuroprotective effects of granulocyte colony-stimulating factor on ischemia-reperfusion injury of the retina. Ophthalmic. Res. 48, 199-207. 10.1159/000340059
- Slater B. J., Mehrabian Z., Guo Y., Hunter A. and Bernstein S. L. (2008). Rodent anterior ischemic optic neuropathy (rAION) induces regional retinal ganglion cell apoptosis with a unique temporal pattern. Invest. Ophthalmol. Vis. Sci. 49, 3671-3676. 10.1167/iovs.07-0504
- Solaroglu I., Jadhav V. and Zhang J. H. (2007). Neuroprotective effect of granulocyte-colony stimulating factor. Front Biosci. 12, 712-724. 10.2741/2095
- Touitou V., Johnson M. A., Guo Y., Miller N. R. and Bernstein S. L. (2013). Sustained neuroprotection from a single intravitreal injection of PGJ2 in a rodent model of anterior ischemic optic neuropathy. Invest. Ophthalmol. Vis. Sci. 54, 7402-7409. 10.1167/iovs.13-12055
- Tsai R. K., Chang C. H. and Wang H. Z. (2008). Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in neurodegeneration after optic nerve crush in rats. Exp. Eye Res. 87, 242-250. 10.1016/j.exer.2008.06.004
- Xu Q., Qaum T. and Adamis A. P. (2001). Sensitive blood-retinal barrier breakdown quantitation using Evans blue. Invest. Ophthalmol. Vis. Sci. 42, 789-794.
- Yin Y., Cui Q., Li Y., Irwin N., Fischer D., Harvey A. R. and Benowitz L. I. (2003). Macrophage-derived factors stimulate optic nerve regeneration. J. Neurosci. 23, 2284-2293.
- Young B., Eggenberger E. and Kaufman D. (2012). Current electrophysiology in ophthalmology: a review. Curr. Opin. Ophthalmol. 23, 497-505. 10.1097/ICU.0b013e328359045e
- Zhang C., Guo Y., Miller N. R. and Bernstein S. L. (2009). Optic nerve infarction and post-ischemic inflammation in the rodent model of anterior ischemic optic neuropathy (rAION). Brain Res. 6, 67-75. 10.1016/j.brainres.2008.12.075
- Zhang C., Guo Y., Slater B. J., Miller N. R. and Bernstein S. L. (2010). Axonal degeneration, regeneration and ganglion cell death in a rodent model of anterior ischemic optic neuropathy (rAION). Exp. Eye Res. 91, 286-292. 10.1016/j.exer.2010.05.021
- Zhao C., Xie Z., Wang P., Wang Y., Lai C., Zhu Z., Liu Z., Cong Y., Zhao Y., Zheng C. et al. (2011). Granulocyte-colony stimulating factor protects memory impairment in the senescence-accelerated mouse (SAM)-P10. Neurol. Res. 33, 354-359. 10.1179/016164110X12807570509970
Source: PubMed